Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

Zhao Yan; Duran Rafael; Bai Wei; Sahu Sonia; Wang Wenjun; Kabus Sven; Lin MingDe; Han Guohong; Geschwind Jean-Francois

首页> 外文期刊>Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment >Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

【24h】

Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

机译：在多相CT中应用哪种标准可以预测使用常规TACE治疗的肝细胞癌患者的早期肿瘤反应：RECIST，MRECIST，EASL或QEASL？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose Our study aimed to evaluate quantitative tumor response assessment (quantitative EASL-[qEASL]) on computed tomography (CT) images in patients with hepatocellular carcinoma (HCC) treated using conventional transarterial chemoembolization (cTACE), compared to existing 1-dimensional and 2-dimensional methods (RECIST, mRECIST, EASL).

机译：目的，我们的研究旨在评估使用常规曲调化疗栓塞（CTACE）治疗的肝细胞癌（HCC）患者的计算断层扫描（CT）图像的定量肿瘤反应评估（定量EASL-κch]），与现有的1维和2相比 - 二维方法（再次，MRecist，EASL）。

著录项

来源
《Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment》 |2018年第3期|共10页
作者
Zhao Yan; Duran Rafael; Bai Wei; Sahu Sonia; Wang Wenjun; Kabus Sven; Lin MingDe; Han Guohong; Geschwind Jean-Francois;
展开▼
作者单位

Fourth Mil Med Univ Xijing Hosp Digest Dis Dept Liver Dis &

Digest Intervent Radiol 27 West;

Yale Univ Sch Med Dept Radiol &

Biomed Imaging New Haven CT USA;

Fourth Mil Med Univ Xijing Hosp Digest Dis Dept Liver Dis &

Digest Intervent Radiol 27 West;

Yale Univ Sch Med Dept Radiol &

Biomed Imaging New Haven CT USA;

Fourth Mil Med Univ Xijing Hosp Digest Dis Dept Liver Dis &

Digest Intervent Radiol 27 West;

Philips Res Hamburg Hamburg Germany;

Yale Univ Sch Med Dept Radiol &

Biomed Imaging New Haven CT USA;

Fourth Mil Med Univ Xijing Hosp Digest Dis Dept Liver Dis &

Digest Intervent Radiol 27 West;

Yale Univ Sch Med Dept Radiol &

Biomed Imaging New Haven CT USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Tumor response; Survival; Three dimensional;

机译：肝细胞癌;rantarterial Chemoembolization;肿瘤反应;生存;三维;

相似文献

外文文献
中文文献
专利

1. Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL? [J] . Zhao Yan, Duran Rafael, Bai Wei, Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment . 2018,第3期

机译：在多相CT中应用哪种标准可以预测使用常规TACE治疗的肝细胞癌患者的早期肿瘤反应：RECIST，MRECIST，EASL或QEASL？
2. Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602 [J] . Upsala journal of medical sciences . 2013,第1期

机译：使用TACE（经导管动脉化学栓塞）治疗的HCC（肝细胞癌）的肿瘤反应评估标准：RECIST（实体瘤反应评估标准）1.1版和mRECIST（改良的RECIST）：JIVROSG-0602
3. Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602 [J] . Upsala journal of medical sciences . 2013,第1期

机译：使用TACE（经导管动脉化学栓塞）治疗的HCC（肝细胞癌）的肿瘤反应评估标准：RECIST（实体瘤反应评估标准）1.1版和mRECIST（改良的RECIST）：JIVROSG-0602
4. Matrix Metalloproteinase-2 and High Vascular Endothelial Growth Factor as Prognostic Markers for Intrahepatic Tumor Recurrence in Hepatocellular Carcinoma Patients Receiving Radiotherapy [C] . Eun-Jung Lee, Jinsil Seong, Yang-Gun Suh, Molecular Medicine TRI-CON. . 2014

机译：基质金属蛋白酶-2和高血管内皮生长因子作为肝细胞癌肝癌患者肝内肿瘤复发的预后标志物，接受放射治疗
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST mRECIST EASL or qEASL? [O] . Yan Zhao, Rafael Duran, Wei Bai, -1

机译：在多相CT中采用哪种标准可以预测使用传统TACE治疗的肝细胞癌患者的早期肿瘤反应：RECISTmRECISTEASL或qEASL？
7. Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL? [O] . Yan Zhao, Rafael Duran, Wei Bai, 2017

机译：在多相CT中应用哪种标准可以预测使用常规TACE治疗的肝细胞癌患者的早期肿瘤反应：RECIST，MRECIST，EASL或QEASL？

Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

摘要

著录项

相似文献

相关主题

期刊订阅